Kanazawa University · Pharmaceutical Sciences Division · 教授

Research keywordslipid nanoparticles・STING agonists・cancer immunotherapy・tumor endothelial targeting・mRNA delivery・NK cell activation・lymph node targeting・nano DDS

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Selective vascular disrupting therapy by lipid nanoparticle-mediated Fas ligand silencing and stimulation of STING.2025
• Impact of in vivo fate of STING agonist-loaded lipid nanoparticles on antitumor immunity.2024
• Vaccination with a combination of STING agonist-loaded lipid nanoparticles and CpG-ODNs protects against lung metastasis via the induction of CD11bhighCD27low memory-like NK cells.2024
• The impact of, and expectations for, lipid nanoparticle technology: From cellular targeting to organelle targeting.2024

• 癌幹細胞を標的とする腫瘍溶解性ウイルスを用いた筋層浸潤性膀胱癌に対する新規治療法2025
• ナノDDSによる生体内機能強化NK細胞の創出と新規がん免疫療法基盤の構築2024
• 炎症性腸疾患におけるスフィンゴ糖脂質による治療を目指した基礎的研究2023
• LNPとスマートポリマーが創るコアシェル構造を有する活性型mRNA送達システム2023

• Official profile